B. Perez Valderrama

Oct 16, 2024 | dialnet.unirioja.es | B. Perez Valderrama |Jorge Aparicio Urtasun |Cristina Diaz |Cristina Díaz |Raquel Luque Caro

Ayuda Buscar en la ayuda Buscar en la ayuda SEOM‑GG clinical guidelines for the management of germ‑cell testicular cancer (2023) José Angel Arranz Arija [1] ; Xavier García del Muro [2] ; Raquel Luque Caro [3] ; María José Méndez Vidal [4] ; Begoña Pérez Valderrama [4] ; Jorge Aparicio [5] ; Miguel Ángel Climent Durán [6] ; Cristina Caballero Díaz [7] ; Ignacio Durán [8] ; Enrique González Billalabeitia [9] [1] Hospital General Universitario Gregorio Marañón, Madrid, Spain [2] Hospital Duran...

Mar 13, 2024 | authors.elsevier.com | S. Gupta |T.B. Powles |B. Perez Valderrama |L. Sengelov

On October 22, 2023, results from the phase 3 trials EV-302, comparing enfortumab vedotin plus pembrolizumab (EV + P) with chemotherapy, and CheckMate 901, comparing gemcitabine, cisplatin, and nivolumab with chemotherapy alone, in metastatic urothelial carcinoma (mUC) were presented at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain [1], [2].